Moffett Susan P, Feingold Eleanor, Barmada M Michael, Damcott Coleen M, Marshall Julie A, Hamman Richard F, Ferrell Robert E
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Metabolism. 2005 Nov;54(11):1552-6. doi: 10.1016/j.metabol.2005.05.025.
The P12A variant in the peroxisome proliferator-activated receptor gamma (PPARgamma) gene has been intensely studied for association with obesity-related or type-2 diabetes-related traits; however, the results have been somewhat inconsistent in different populations. We genotyped a large cohort of Hispanic and non-Hispanic white individuals from the San Luis Valley Diabetes Study for P12A and another common variant, C161-->T, in the PPARgamma gene to determine if these sites were associated with fasting glucose, insulin, free fatty acid levels, insulin sensitivity, or body fat. There were no statistically significant frequency differences at these two sites between Hispanic and non-Hispanic individuals. No significant association with the metabolic phenotypes was observed for either of the polymorphisms in men; however, in women, significant associations were shown between the C161-->T variant and fasting insulin (P=.008) and the homeostasis model assessment of insulin resistance (HOMA IR; P=.007). After adjusting for age, smoking, fat mass, and skin reflectance, linear regression showed that C161-->T explained 1.5% of the variation in both fasting insulin (P=.031) and HOMA IR (P=.028) whereas P12A contributed only 0.04% (fasting insulin, P=.268) and 0.02% (HOMA IR, P=.418) to the total trait variation. In the San Luis Valley Diabetes Study female patients, C161-->T appears to be a better predictor of fasting insulin levels and insulin resistance than P12A although the effect of this variant is small. These results support the hypothesis that C161-->T is in linkage disequilibrium with unidentified functional variation in PPARgamma or in a linked gene. This could explain some of the inconsistencies in the P12A association studies as the allele frequency and level of linkage disequilibrium of another functional polymorphism in the region could vary in different populations.
过氧化物酶体增殖物激活受体γ(PPARγ)基因中的P12A变异体已被深入研究与肥胖相关或2型糖尿病相关性状的关联;然而,不同人群的研究结果有些不一致。我们对来自圣路易斯谷糖尿病研究的一大群西班牙裔和非西班牙裔白人个体进行了PPARγ基因中P12A以及另一个常见变异体C161→T的基因分型,以确定这些位点是否与空腹血糖、胰岛素、游离脂肪酸水平、胰岛素敏感性或体脂相关。西班牙裔和非西班牙裔个体在这两个位点上没有统计学上的显著频率差异。在男性中,这两种多态性均未观察到与代谢表型有显著关联;然而,在女性中,C161→T变异体与空腹胰岛素(P = 0.008)以及胰岛素抵抗的稳态模型评估(HOMA-IR;P = 0.007)之间存在显著关联。在调整年龄、吸烟、脂肪量和皮肤反射率后,线性回归显示C161→T解释了空腹胰岛素(P = 0.031)和HOMA-IR(P = 0.028)变异的1.5%,而P12A对总性状变异的贡献仅为0.04%(空腹胰岛素,P = 0.268)和0.02%(HOMA-IR,P = 0.418)。在圣路易斯谷糖尿病研究的女性患者中,尽管该变异体的作用较小,但C161→T似乎比P12A更能预测空腹胰岛素水平和胰岛素抵抗。这些结果支持了这样的假设,即C161→T与PPARγ或连锁基因中未鉴定的功能变异处于连锁不平衡状态。这可以解释P12A关联研究中的一些不一致性,因为该区域另一个功能多态性的等位基因频率和连锁不平衡水平在不同人群中可能有所不同。